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Abstract 
 
 
 Similar to human disease, inhalation of small particle aerosols of H5N1 highly 
pathogenic avian influenza virus by cynomologus macaques leads to fulminant pneumonia, 
acute respiratory disease syndrome (ARDS), and fatality. Although aspects of the viral 
pathogenesis are understood, many of the finer mechanisms of H5N1 disease progression 
remain unclear. The severity of disease and associated mortality rate highlight the necessity to 
better understand this public health threat and potential bioweapon. During H5N1 infection, 
interferon-α and proinflammatory cytokines and chemokines markedly increase in expression 
within lung epithelial tissue and distal airways.  This profound inflammation is characteristic of 
the pro-inflammatory cell death pathway known as pyroptosis. Yet, the role of pyroptosis and its 
initiator, caspase-1, in H5N1 influenza pathogenesis is unknown. Using immunofluorescent 
microscopy in situ, I identified active caspase-1, active IL-1β, and neutrophil extracellular traps 
(NETs) in association with influenza A nucleoprotein. I hypothesized that after H5N1 aerosol 
inoculation lung epithelial cells undergo caspase-1 dependent pyroptosis, leading to recruitment 
signaling of neutrophils to the site of infection and the production of NETs as secondary host 
immune response. NETosis, or the presentation of neutrophil extracellular traps from living or 
suicidal neutrophils, complicates the fulminant pneumonia present during H5N1 influenza 
disease progression.  By trapping fluid and viral particles within the lung, it is likely that NETs 
prevent clearance of fluid buildup and viral particles within the highly inflamed lung tissue. I  
v 
 
further identified and characterized apoptosis-associated speck like proteins (ASC) containing a 
caspase recruitment domain (CARD) within lung epithelial cells that generate IL-1β.  I found that 
the expression of caspase-1 correlated with NET expression and disease severity after aerosol 
challenge. These data suggest that caspase-1 driven inflammation of lung tissues, including 
pyroptotic cell death, contribute to disease severity in H5N1 influenza. What’s more, in terms of 
public health significance; these findings help clarify cellular mechanisms associated with H5N1 
disease progression furthering the understanding of H5N1 disease and could support research 
into the identification of novel therapeutics, such as using caspase-1 inhibitors to control 
inflammation and prevent severe disease progression in infected subjects. 
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1.0 Introduction 
 
 
1.1 H5N1 Highly Pathogenic Avian Influenza 
 
 
Like seasonal influenza A, H5N1 highly pathogenic avian influenza is a member of the 
Orthomyxoviridae family whose virus genome are composed of 8 discrete negative sense RNA 
strand segments [1, 2].  These segments encode:  MS1 (m1) and MS2 (m2), interferon 
antagonist NS1, export protein NEP, hemagglutinin protein HA, neuraminidase protein NA, 
polymerase protein PA, polymerase proteins PB1, PB2, and PB; and PB1-F2, which is thought 
to induce apoptosis [1, 2]. The virion itself contains two surface glycoproteins hemagglutinin, 
which binds and internalizes the virion to cells, and neuraminidase, which facilitates the release 
of new virions from infected cells [1, 2]. Influenza subtyping is denoted by hemagglutinin and 
neuraminidase antigenicity.  For instance, the H5 subtype denotes the hemagglutinin of H5N1 
highly pathogenic avian influenza [2]. 
 Unlike seasonal flu H5N1 influenza is normally circulated in wild or domestic populations 
of land fowl or waterfowl.  Avian influenza virus preferentially binds to galactose linked to sialic 
acid via α-2,3 linkages in waterfowl or domestic birds.  Human influenza strains and other 
mammal influenza strains typically attach to galactose linked to sialic acid via α-2,6 linkages [1, 
3-5]. In human or other mammals that can be infected with H5N1 influenza, sialic acid bound to 
galactose via α-2,3 linkages are commonly found in the lower respiratory tract and not the upper 
respiratory tract; this may account for why H5N1 influenza does not readily transmit from person 
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to person.  Typically, avian influenza is asymptomatic in avian hosts; however influenza of the 
H5 or H7 subtype are found to be either high or low pathogenicity and can in high pathogenicity 
cases lead to fatality in domestic or wild birds [1, 2]. 
 
1.2 Human Infection 
 
 
The first identified human cases of H5N1 influenza occurred in May of 1997, with the 
infection of a 3-year-old Chinese boy as the putative index case [6, 7].  The 3-year-old initially 
presented with high-grade fever, dry cough, and sore throat; however, his symptoms worsened 
over a period of four days, until on May 16th of 1997 he was admitted to another hospital with 
leukopenia, respiratory distress, and hypoxemia suggestive of acute respiratory disease 
syndrome (ARDS) which proved fatal [6]. In November and December of the same year, 5 more 
patients succumbed to the disease after coming in direct contact with infected domestic fowl [6, 
7].  
 From 1997 onwards, the disease seemingly went dormant until its reemergence in 2003, 
when two more individuals contracted the disease in Hong Kong [8].  Since its reemergence in 
2003, greater than 850 cases worldwide have been reported, with a case fatality ratio near 50% 
or greater [5, 6]. 
 In human infection, the H5N1 virus infects human alveolar epithelial cells, causing cell 
death, and a loss of alveolar epithelial barrier function [1, 2, 6].  This causes a viral pneumonia 
seen in all human cases, leading to cyanosis, hypoxemia, and pulmonary edema, characteristic 
of ARDS [2, 6]. In fatal cases, this can induce respiratory failure and multiple organ failure in the 
host [2, 6].  The etiology of this cell death and increased inflammation in the lung is not known.  
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1.3 Animal Models 
 
 
 H5N1 influenza can infect large a number of mammalian species other than humans 
including cats, dogs, mice, rats, ferrets, and non-human primates [9]. H5N1 influenza virus 
infects primarily type 2 pneumocytes, alveolar macrophages, and non-ciliated cuboidal epithelial 
cells in terminal bronchioles located within the lower respiratory tract of humans and other 
mammals [2, 4, 7]. In addition, a previous study has documented influenza a virus infection at 
the soft palate at the roof of the mouth [10].    However, the presentation of disease differs 
between various animal models, favoring certain models for scrutiny of hallmarks of disease 
progression such as fulminant pneumonia presentation over others.  
 
1.4 Pathogenesis of H5N1 Influenza in Cynomologus Macaques 
 
 
Our group has shown that cynomologus macaques with H5N1 influenza via aerosol route 
present characteristic hallmarks of disease similar to those found in human disease [9, 11].  
Following a short incubation period, of 1-2 days, infection rapidly progresses to severe 
pneumonia due to loss of the alveolar epithelial barrier [4, 9, 11]. This is followed by ARDS and 
finally death due to respiratory failure.  ARDS brought on by a primary viral pneumonia is 
principally characterized by cyanosis, hypoxemia, pulmonary edema, and an increasing rate of 
respiratory failure, which in cases of highly pathogenic avian influenza leads to a multiple organ 
failure of the host [9, 11, 12]. In stark contrast to experiments using aerosolized virus, previous 
studies that utilize intra-tracheal or intra-nasal inoculation via liquid suspension produced low 
mortality in cynomologus macaques [13-19].  In studies that use intra-tracheal inoculation, most 
4 
 
animals survive initial challenge and do not present normal disease symptology.  The reason for 
these clinical differences is that liquid suspensions of H5N1 influenza fail to reach their target 
cells in the alveoli, and instead are cleared by the mucociliary apparatus of the upper respiratory 
track.  Unlike liquid suspension studies however, the previous study by our group showed 
symptology similar to human disease after introduction of the virus by aerosolized droplets 
rather than by mucosal introduction [11].  Aerosolized droplets of H5N1 influenza displayed 
disease pathogenesis similar to human disease and lead to high mortality rate in all 
cynomologus macaques. This new model presents a powerful tool to study mechanisms of 
disease pathogenesis.  
 
1.5 Study of Disease Mechanism 
 
Although some mechanisms of H5N1 influenza pathogenesis are understood, 
mechanisms on a cellular level surrounding H5N1 influenza disease remain unclear. Emerging 
evidence suggests that a major factor in disease severity emerges not directly from 
complications from viral infection, but from the subsequent innate host response. The innate 
immune response to H5N1 influenza infection consists of a dramatic increase in pro-
inflammatory cytokine and chemokine levels within the host’s infected tissue as well as 
systemically. A “cytokine storm”, or disproportionate release of inflammatory cytokines and 
chemokines within the host as a response to infection, has been suggested as a causative 
factor of the ARDS that is characteristic of human disease [20, 21]. Increased plasma levels of 
pro-inflammatory cytokines, including IL-1β, MCP-1, IL-6, IL-8 and TNF-α in both human cases 
and cynomologus macaques infected by aerosol support the hypothesis of a central role played 
by the “cytokine storm” in disease progression, but what drives this response is unclear [11].  
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1.6 The Inflammasome 
 
With the high expression of pro-inflammatory cytokines during H5N1 influenza infection, 
cells infected with virus generate a multiprotein complex called an inflammasome. The 
inflammasome forms after innate immune response recognition of a pathogen by pathogen 
associated molecular patterns (PAMPs), or danger associated molecular patterns (DAMPs), in 
cases of invading microbial pathogens or endogenous cell stress respectively [22-26]. Pattern 
recognition receptors (PRR), such as toll-like receptors (TLRs), NOD-like receptors, Rig-like 
helicases, or C-type lectin receptors, are cell receptors that identify PAMPs or DAMPs in a cell’s 
environment [22, 23, 25, 26].  Endogenous cell stresses or invading pathogens recognized 
through pattern associated recognition receptors (PRR) generate inflammasome formation 
producing inflammation at the sites of recognition.  Stimuli like invading pathogens can cause 
absent in melanoma (AIM)-like receptors, such as AIM2 or NLRs to form oligomers leading to 
cleavage of pro-caspase-1 and activation of the caspase-1 scaffold [23, 25]. Once started, the 
caspase-1 scaffold, including active caspase-1, cleaves of pro-inflammatory IL-1 family 
cytokines, such as IL-1β and IL-18, and this leads to cell death by pyroptosis, a form of pro-
inflammatory regulated cell death [24, 25, 27]. The potential caspase-1 mediated inflammatory 
cell death in H5N1 disease pathogenesis has not yet been explored. To understand this process 
we need to first define the different inflammasomes and cell death pathways. There are various 
types of inflammasomes as discussed below. 
 
1.6.1 NLRP3 Inflammasome 
 
 Compared to other inflammasome oligomers, cryopyrin or NLRP3 has the widest array 
of reactivity to stimuli, which may be attributable to downstream events from initial recognition of 
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danger signals that activate NLRP3 rather than individual agonists [22, 23].  Most cell types that 
induce an NLRP3 inflammasome require priming of NLRP3, which includes lipopolysaccharide 
(LPS) binding to TLR4 for example.  Once primed, the receptor can respond to stimuli, and 
inflammasome assembly begins. Such receptive stimuli include pore-forming toxins, nucleic 
acids; fungal, bacterial, or viral pathogens; excess of internal ATP, crystalline substances, and 
hyaluronan, a scaffold protein used in a variety of cell types [22, 23, 28, 29]. Cell mechanisms 
that induce NLRP3 activation include potassium efflux, generation of mitochondrial reactive 
oxygen species, translocation of NLRP3 to the mitochondria, release of mitochondrial DNA, and 
the release of cathepsins to the cytosol after lysosomal destabilization. However, all these 
mechanisms do not apply to the variety of agonists for NLRP3; the precise mechanisms after 
activation remain under study [23, 26]. After activation, inflammasome assembly can occur, but 
not without ubiquitination of apoptosis associated speck like proteins (ASC) containing a 
caspase recruitment domain (CARD). Inflammasome assembly begins with the NLRP3 
nucleotide oligomerization binding domain, facilitating NLRP3 Pyrin containing domains to serve 
as a scaffold allowing pyrin-pyrin interactions with ASC.  This causes the formation of filaments 
of ASC allowing pro-caspase to bind via c-terminal CARD interactions, causing an 
autoproteolytic maturation of pro-caspase-1 to its active forms [22, 23, 30].  
 
1.6.2 NLRC4 Inflammasome 
 
 Unlike NLRP3, NLRC4 has a narrow range of stimuli that cause its activation.  NLRC4 is 
activated through bacterial type III secretory systems. Once activated NLRC4 complexes with 
NLR family apoptosis inhibitory protein (NAIP), forming the NAIP-NLRC4 inflammasome [22]. 
For oligomerization autoinhibition of NLRC4 must be relieved; however currently it is not 
understood how this occurs [22, 23]. Once oligomerized, the NAIP-NLRC4 inflammasome 
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interacts with ASC to form filaments of ASC, like the NLRP3 Inflammasome.  It is important to 
note that although the NLRC4 inflammasome does contain a CARD domain, the inflammasome 
requires ASC to be maximally efficient [23], as without ASC autoproteolytic maturation of pro-
caspase-1 cannot occur.  
 
1.6.3 AIM2 Inflammasome 
 
 The AIM2 inflammasome directly interacts with cytosolic double stranded DNA stimuli 
due to the HIN (hematopoietic expression, interferon-inducible nature, and nuclear localization)-
200 domain [22, 26]. The AIM2 inflammasome autoinhibits itself in its inactive state, due to 
interaction between the two domains within the inflammasome, but can relieve the inhibition 
once the sugar phosphate backbone of DNA from an invading pathogen is presented [22, 26]. 
Once bound, the DNA displaces pyrin domain (PYD) interactions, allowing the PYD to then 
recruit ASC to the oligomer. The AIM2 inflammasome is not sequence specific, but accepts 
nonspecific sequences of dsDNA longer than 80 base pairs [22].  Once free, the PYD interacts 
through PYD-PYD homotypic binding with ASC, causing the formation of ASC filaments.  
 
1.6.4 The ASC Pyroptosome 
 
In addition to the formation of the inflammasome oligomer, ASC also can independently 
act as a supramolecular assembly to induce caspase-1 dependent pro-inflammatory cell death, 
or pyroptosis, within cells. The ASC pyroptosome is a supramolecular assembly of 1-2 µm in 
diameter that can form in response to pro-inflammatory stimuli independently [26, 30-32]. 
Primary formation of the ASC supramolecular assembly was found to be because of potassium 
depletion, causing the formation of an oligomer made of ASC dimers [31]. The dimers and the 
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oligomer itself form due to homotypic interaction between PYD domains in ASC molecules, 
however once formed the supramolecular assembly has supposed enhanced intermolecular 
attraction, leading to the formation of the ASC pyroptosome in the cytoplasm [30, 31].  The ASC 
pyroptosome then cleaves endogenous pro-caspase 1 generating the active form caspase-1, 
leading to caspase-1 dependent pyroptosis of the cell and rupture of the cellular membrane [31, 
32]. 
 
1.7 Cell Death 
 
 Cell death and the variation of cell death pathways that can occur within a host’s tissue 
is an important distinction when considering disease pathogenesis.  Broadly, cell death can fall 
into two major categories: accidental cell death (ACD) and regulated cell death (RCD). ACD is a 
catastrophic instantaneous and non-regulated demise of one or multiple cell due to exposure 
from severe physical, chemical, or mechanical force, usually because of harm to the organism 
or host [33].  RCD is, as termed, associated with regulation and organism homeostasis, 
focusing on the health of the organism or colony, rather than the individual cell [33].   More 
specifically, RCD falls into several cell death pathways including more common cell death 
pathways: intrinsic apoptosis, extrinsic apoptosis, pyroptosis, necroptosis, and mitochondrial 
permeability transition (MPT)-driven necrosis.  RCD also falls into less common cell death 
pathways such as ferroptosis, parthanatos, entotic cell death, lysosomal-dependent cell death, 
autophagy-dependent cell death, mitotic catastrophe, NETotic Cell death or NETosis, and 
immunologic cell death [33].  It is important to note, that although some RCD are less common 
than others they still can occur if given the correct conditions to do so.  All RCD cell death 
pathways are summarized (Table 1), however for this thesis, only the major cell death pathways 
will be extensively discussed. NETotic cell death or NETosis is extensively covered in its own 
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section in this introduction, as it can occur suicidally, where the neutrophil dies, or vitally, where 
the neutrophil returns to some normal processes.  
Table 1. Regulated Cell Death Pathways 
Summary of regulated cell death pathway definitions [33]. 
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1.7.1 Intrinsic Apoptosis 
 
 Intrinsic apoptosis occurs through a series of initiator and effector caspases, including 
interactions with cellular components such as BCL2 pro-apoptotic and anti-apoptotic family 
proteins. Initiator caspases include caspase 2, 8, and 9, and are associated with the initial outer 
mitochondrial membrane permeabilization [25, 34]. Effector or executioner caspases: caspase 
3, 6, and 7 are known for the cellular fragmentation and characteristic nuclear and cytoplasmic 
condensation seen in both intrinsic and extrinsic apoptosis [25, 33].  
 After recognition through DAMPs, b cell lymphoma 2 (BCL2) associated pro-apoptotic 
and anti-apoptotic family proteins initiate intrinsic apoptosis.  BCL2 associated X protein (BAX) 
and BCL2 antagonist/killer 1 (BAK) begin initiation by pooling on the surface of the outer 
mitochondrial membrane [35].  BAX is normally found cycling between the cytosol and 
mitochondrial membrane, while BAK is normally found within the lipid bilayer of the 
mitochondrial membrane [36, 37]. Once DAMPs are recognized, BCL2 homology 3 (BH3)-only 
activator proteins can indirectly or directly activate pooling of BAX and BAK to the surface of the 
mitochondria [33, 36, 37]. Pooling of BAX and BAK causes dimer-dimer oligomerization of BAX 
forming ring like or arc like oligomer pores, causing mitochondrial outer membrane 
permeabilization [33, 38-40].  Anti-apoptotic members of the BCL2 family can regulate the 
interaction of apoptotic BCL2 factors through direct binding, however a BH3-only sensitizer, 
such as hara-kiri (HRK), BCL2 interacting protein, can cause outer membrane permeabilization 
without BAX or BAK [33, 38]. 
 Once the outer mitochondrial membrane has been permeabilized, pro-apoptotic factors 
cytochrome c and secondary mitochondrial activator of caspases (SMAC) are released from the 
mitochondrial intermembrane space [33, 34, 41, 42]. Cytochrome C binds to apoptotic peptidase 
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activating factor 1 and pro-caspase 9 to form the apoptosome, which autocatalytically matures 
caspase 9 through CARDs [41, 42]. Caspase 9 once matured, activates caspase 7 and caspase 
3, the two of which ultimately induce cellular demise [43-45]. Caspase 7 and caspase 3 cause 
DNA fragmentation, phosphatidylserine exposure and apoptotic bodies characteristic of the 
apoptotic cell death pathway [43-45].   
 One of the most important regulation proteins in intrinsic apoptosis is X-linked inhibitor of 
apoptosis (XIAP) of the inhibitor of apoptosis family (IAP). Cytosolic SMAC is necessary to 
prevent inhibition of apoptosis through IAPs by direct interaction. To directly interact with IAPs 
SMAC must undergo a proteolytic maturation allowing for the IAP binding domain to become 
available to prevent XIAP [33, 46, 47].  Without this interaction XIAP can directly block the 
caspase cascade associated with cellular demise by physically blocking caspase 9 from forming 
the necessary dimers, leading to inhibition of the apoptozole and subsequent inhibition of 
cleavage of caspases 7 and 3 [46, 47]. XIAP is the only member of the IAP family to directly 
prevent the caspase cascade, while other IAPs drive upregulation of anti-apoptotic factors, 
trigger increased expression of pro-survival NF-ƙb, or degrade SMAC prior to its proteolytic 
maturation [46, 47]. 
 
1.7.2 Extrinsic Apoptosis 
 
 
 Unlike intrinsic apoptosis, extrinsic apoptosis is an RCD initiated by binding or loss of 
ligands on active receptors in association with the extracellular microenvironment. Extrinsic 
apoptosis is driven by plasma membrane receptors which fall either into death receptor or 
dependence receptor categories [33, 48, 49].  
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 Death receptors are activated once a corresponding ligand binds to the plasma 
membrane receptor.  Death receptors, such as Fas cell surface death receptor or TNF receptor 
superfamily member 10a, assemble multiprotein complexes at the intracellular tail of the 
receptor once a corresponding ligand is recognized [33, 48, 49]. The multiprotein complex, 
death-inducing signaling complex, regulates functions and activation of caspase-8 or caspase-
10, which form filaments leading to their autoproteolytic maturation.  This autoproteolytic 
maturation allows for cleavage of effector caspases, caspase-7 and caspase-3, which lead to 
cellular demise as in intrinsic apoptosis [33, 50, 51]. Caspase-8 fas associated via death domain 
like apoptosis regulation (c-flip), can modulate oligomer formation of caspase-8 preventing 
formation of caspase-8 filaments. Caspase-8 can prevent this by cleaving the long variant of c-
flip and forming a heterodimer complex, which will favor caspase-8 oligomer formation [52-54].  
 There are 2 types of cell death pathways which occur from death receptor activating. 
These cell death pathways vary by the types of cells that they can occur in. Type 1, which 
occurs in thymocytes and mature lymphocytes, utilizes caspase-3 and caspase-7 to drive RCD 
and cannot be restrained by anti-apoptotic BCL2 proteins, loss of BAX or BAK, or loss of BH3-
only activator BH3 interacting death domain agonist (BID) [33, 55]. Type 2, however, is 
restrained by XIAP, and requires BID cleavage by caspase-8 to continue RCD [55, 56]. Cleaved 
BID, or truncated form of BID (tBID), will then travel to the outer mitochondrial membrane and 
will act as a BH3-only activator to drive caspase-9 driven BAK and BAX dependent regulated 
cell death [33, 57, 58].  
 Dependence receptors are activated once levels of specific binding ligand fall below 
specific threshold for the cell. Dependence receptors, such as netrin 1 receptors DCC netrin 1 
receptor (DCC) and sonic hedgehog receptor patched 1 (PTCH1), normally promote cell 
survival and proliferation [33, 59].  However, once their respective ligand levels drop below 
threshold, each dependence receptor undergoes distinct lethal signaling cascades.  In the case 
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of PTHC1 and DCC, both dependence receptors lead to caspase-9 activation and effector 
caspase cascades causing cellular demise [59, 60].  
  
1.7.3 Pyroptosis 
 
 A more recently described form of cell death is pyroptosis. Associated with extracellular 
and intracellular homeostasis related to innate immunity, pyroptosis is an RCD commonly 
distinguished by morphological features such as chromatin condensation, cellular swelling, and 
plasma membrane permeabilization [24, 33, 61].  Pyroptosis is commonly associated with 
pathological conditions like lethal septic shock and is of considerable interest in innate immunity 
due to its pro-inflammatory nature [61, 62].  Pyroptosis is driven by caspases such as caspase-
1, caspase 3, caspase 11, caspase 4 and caspase 5 after initiation from pathogen invasion [24, 
61, 63].  
 When gram-negative bacteria invade a cell, cytosolic LPS is recognized by pattern 
recognition receptors (PRRs) murine caspase-11, caspase-4, and caspase-5, which when 
activated lead to CARD domain interactions and caspase oligomerization [24, 27].  Murine 
caspase-11, caspase-4, and caspase-5 act as PRRs, and after oligomerization catalyze 
proteolytic cleavage of the pore forming complex gasdermin-d (GSDMD), which directly 
mediates pyroptosis [64-66]. GSDMD normally is inactive as its two domains: the C-terminal 
repressor domain (GSDMD-C) and N-terminal pore-forming domain (GSDMD-N) interact with 
each other preventing activation [27, 33, 64].  However once cleaved, GSDMD-N can 
translocate to the inner leaflet of the plasma membrane where its binds to cardiolipin [67, 68].  
Once bound, GSDMD-N forms pores with an inner diameter of 10-14 nanometers, made of 16 
symmetric protomers, which cause rapid plasma membrane permeabilization [33, 66].  
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 In addition, caspase-1 is associated with pyroptosis caused by bacteria and viruses, 
including influenza, that are recognized by DAMPs or microbe-associated molecular patterns 
[69]. Caspase-1 pyroptosis is important as it can cause pyroptosis cell death of macrophages 
leading to the formation of pore-induce intracellular traps, trapping intracellular invasive bacteria 
or viruses until efferocytosis or removal by phagocytes [27, 61]. After cleavage of GSDMD by 
any of the active caspases, pro-inflammatory IL-1β and IL-18 are released and cleaved by the 
active caspase.  It is worth mentioning, that other N-terminal domains from other members of 
the gasdermin family have been shown to cause pyroptosis, as it is not gasdermin-d alone [27, 
33].  
 
1.7.4 MPT-driven necrosis 
 
 MPT-driven necrosis is an RCD characterized by abrupt loss of impermeability of the 
inner mitochondrial membrane (IMM) to small solutes, a rapid dissipation of transmembrane 
potential, and the osmotic breakdown of both mitochondrial membranes [33, 70, 71].  MPT-
driven necrosis is commonly initiated by severe oxidative stress and a cytosolic overload of 
calcium ions resulting in characteristic necrotic cell death presentation [33, 70]. MPT-driven 
necrosis follows the opening of the permeability transition pore complex, a supramolecular 
complex assembled at the junctions between the inner and outer mitochondrial membranes [62, 
72]. The precise biochemical mechanism is still under investigation and intense debate; 
however, it is known that cyclophilin D (CYPD) is essential for MPT induction [33, 73]. CYPDs 
requirement has been established by genetic tools, however it is generally agreed that it is not a 
part of the permeability transition pore complex’s pore-forming unit [73, 74].  
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1.7.5 Necroptosis 
 
 Associated with specific death receptors in response to intracellular and or extracellular 
microenvironment disturbance, necroptosis is a form of RCD involving receptor-interacting 
serine/threonine-protein kinase (RIPK) 3, RIPK 1, and mixed lineage kinase domain like pseudo 
kinase (MLKL) [33, 75, 76]. Necroptosis is primarily related to the meditation between adaptive 
response and stress responses; however, it has also been associated with developmental 
safeguard programs, and maintenance of adult T-cell homeostasis [77, 78].  Death receptors, 
such as FAS cell surface death receptor and TNF superfamily receptor 1 or PRRs like TLR4 or 
Z-DNA binding protein 1 (ZBP1) initiate necroptosis [33, 79].  Necroptosis depends upon the 
simultaneous interaction of RIPK3 and MLKL, after activation of RIPK3 with RIPK1 through 
interaction of a death receptor such as TNFR1 [75, 80]. Interactions between RIPK3 and RIPK1 
are reliant on the physical interactions between the two RIP homotypic interaction motif (RHIM) 
domains and the catalytic activity of RIPK1 [81-83].  
 If RIPK1 is unavailable, 2 methods independent of RIPK1 but dependent on RHIM 
domain interactions can occur.  One method involves activation of death receptors or PRRs via 
DAMPs or double stranded RNA recognition leading to RIPK3 activation [79].  Alternatively, 
ZBP1 can promote type 1 interferon synthesis and NF-ƙb activation, as it acts as a sensor for 
cytosolic DNA [84]. 
 Once activated, RIPK3 catalyzes phosphorylation of MLKL leading to the formation of 
MLKL oligomers [80, 85].  These MLKL oligomers translocate to the plasma membrane, where 
they bind to specific phosphatidylinositol phosphate species, triggering the characteristic plasma 
membrane permeabilization [33, 85].  
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 Oligomerization of MLKL causes a cascade of intracellular processes including an influx 
of calcium 2+ ions and phosphotidyl serine (PS) exposure, leading to the formation of PS 
bubbles on the membrane surface [85].  The breakdown of the PS bubbles is negatively 
regulated by endosomal sorting complex required transport (ESCRT)-III machinery [86, 87]. 
Once attached to the plasma membrane, MLKL activates proteases of the a disintegrin and 
metalloproteinase (ADAM) family initiating shedding of plasma membrane proteins and the 
formation of permeant magnesium 2+ channels [88, 89].  
 In addition, downstream activity of TNFR1 ligation promotes the formation of RIPK1-
containing RIPK3 containing amyloid-like complex, known as the necrosome [81, 90]. It is 
important to note, that not all the core components of MLKL necroptosis are shared across 
animal species.  Specifically, RIPK3 (but not MLKL) and MLKL (but not RIPK3) necroptosis 
have occur, and some species are missing one or both proteins [91, 92].  As a result, MLKL 
necroptosis signaling pathways are still not fully understood and require more investigation [33].  
 
1.7.6 NETosis and NETotic Cell death 
 
 NETotic cell death is a form of RCD directly affecting polymorphonuclear neutrophils 
upon stimulation of specific PRRs, such as TLR4, TLR7, and TLR8 [33, 71, 93-96].  NETotic cell 
death is characterized by neutrophil extrusion of histone containing meshwork of chromatin 
fibers and granular or cytoplasmic proteins, otherwise known as neutrophil extracellular traps 
(NETs) [71, 93-96]. These NETs are secondary immune system responses to infection and act 
as a stable net of chromatin fibers in the extracellular matrix (ECM) to trap and degrade 
invading bacteria, viruses or fungi [71, 93-97].  
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 NETotic cell death is initiated by PRRs on the membrane surface on the neutrophil. 
Once initiated, NADPH oxidases and a signaling pathways including Raf-1 proto-oncogenic, 
serine/threonine kinase (RAF1), mitogen-activated protein kinase 2 (MAP2K), and mitogen 
activated protein kinase 1 (ERK2) are induced leading the generation of intracellular reactive 
oxygen species (ROS) [33, 93-95].  This intracellular ROS triggers the release of elastase, 
neutrophil expressed (ELANE) and myeloperoxidase (MPO) from neutrophil granules in the 
cytosol [33, 93-95].  MPO will translocate to the nuclease where with ROS promote MPO-
dependent proteolytic activity of ELANE, which aggregates of ELANE into the cells cytosol [33, 
71, 93-95]. Cytosolic ELANE pools thereby catalyze proteolysis of F-actin, impairing the cells 
cytoskeleton, while nuclear ELANE pools in conjunction with MPO promote the degradation of 
histones [33, 71, 93, 98].  Additionally, nuclear ELANE pools and MPO cause chromatin 
decondensation, allowing for chromatin fibers to be released from the cells once the plasma 
membrane ruptures [33, 93, 98]. Finally, peptidyl arginine deaminase 4 (PADI4) participates in 
chromatin dispersion into the ECM after RCD. Some studies have suggested that NETotic cell 
death is partly dependent on the necroptic apparatus and inhibitors of RIPK1 and MLKL have 
been shown to inhibit NET formation [33, 93, 98].  
 Unlike NETotic cell death, NETosis, sometime referred to as “vital NETosis”, does not 
depend on the permeabilization of the plasma membrane and instead uses vesicular trafficking 
to export chromatin fibers to the ECM [94, 96]. Although not fully understood, polymorphic 
nuclear cells (PMNs) have been shown to rapidly release NETs and maintain cellular function, 
even once the cell is anuclear [33, 94, 96]. These anuclear neutrophils then act as anuclear 
cytoplasts to trap invading bacteria [33, 94, 96].  
 After release of the NETs, bacteria and viruses can be trapped via histone or nucleic 
acid or deoxyribose backbone interactions with the chromatin fibers [93-95, 98].  This allows the 
invading microbe to either be effercytosed by a phagocyte along with the remnants of the NET, 
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or to die without phagocytic interaction, as NETs have been shown to be microbicidal [93, 94, 
97, 98]. Following removal of foreign infectious material, NETs will persist for several days, after 
which they are dismantled via secreted plasma nuclease DNase 1 [98, 99]. This dismantling 
however does not seem to fully clear the NET proteins, which persist after DNase 1 interaction, 
suggesting that there is another mechanism for clearance [98, 100].  Although potentially 
beneficial, NETs produced via NETosis or NETotic cell death have been shown to cause 
thrombocypenia after activation of TLRs via histones within the chromatin fibers [33, 69, 94, 98].   
 
1.8 Previous Studies with H5N1 Influenza 
 
 Previous studies in H5N1 influenza have described apoptosis occurring at the site of 
infection and show high increases in pro-inflammatory cytokine generation both at the site of 
infection and systemically throughout the host [11, 21, 101-103].  However, there are few data 
to suggest that apoptosis of alveolar epithelial cells truly contributes to inflammatory cytokine 
generation or H5N1 disease. Instead, it appears to be more likely that pyroptotic cell death, a 
pro-inflammatory cell death pathway of alveolar epithelial cells, occurs at the site of infection 
and drives inflammatory cytokine generation. 
One reason behind the lack of clarity with data generated from previous studies is the 
lack of an animal model that reproduces severe disease.  Previous studies have demonstrated 
apoptosis occurring in the lower respiratory tract made use of inoculation with liquid 
suspensions or liquid droplets containing H5N1 HPAI via intra-tracheal or mucosal introduction 
[102, 103]. Unfortunately, utilizing liquid suspensions on mucosal surfaces does not allow the 
virus to reach the deep lung, as mucocilliary clearance prevents the virus from reaching the 
targeted sialic acid linkages.  As well, it is possible that the way apoptosis is defined in these 
studies is not definitive.  Wonderlich et al. shows disease progression within cynomologus 
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macaques more akin to human disease as the study group aerosoloized H5N1 to recapitulate 
natural infection and to allow the virus to reach the lower respiratory tract more easily than it can 
through intra-tracheal liquid suspension [11]. 
In addition, some studies suggest an active role of NETosis from recruited neutrophils to 
the site of infection [95, 104]. As previously described, NETs from NETosis are thought to be 
detrimental to the host as they can trap fluid, viral particles, and bacteria allowing for greater cell 
infections and difficulty in clearing fluid buildup prior to fulminant pneumonia. Currently there is 
not enough data to support this, and NETosis within H5N1 influenza requires more research.  
Finally, there have been studies to suggest that H5N1 influenza interacts directly within 
inflammasome generation, leading to pro-inflammatory cytokine generation in tissue at the site 
of infection [105-109]. However, the means of which H5N1 influenza is able to do this, and 
which inflammasomes are being utilized by the host, are both currently understudied and 
require more research.  
Factors including pyroptotic cell death, pro-inflammatory cytokine generation, 
inflammasome interaction and NETosis require research in relevant animals models during 
disease progression to better understand cellular mechanisms and host response to H5N1 
influenza.  More research into cellular mechanisms can help to better understand disease 
pathogenesis and illuminate possible therapeutic treatments.   
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2.0 Public Health Significance 
 
Seasonal influenza A virus is a respiratory pathogen that has a large annual effect on 
the human population health with nearly 50,000 people dying each year in the US directly from 
infection or due to secondary complications associated with influenza infection [110].  While the 
burden of seasonal influenza disease is high, there is a larger public health concern associated 
with novel influenza A strains that have no prior population immunity and are not included in 
yearly vaccines. Such strains, like the A/2009/H1N1, could cause population-wide or nation-
wide pandemics, as seen in the 2009 H1N1 influenza virus pandemic. In addition to influenza A 
strains with no prior immunity, strains which share an animal carrier or intermediate host are a 
primary focus, as the next severe pandemic could be cause by recombinant or altered strains. 
Highly pathogenic avian influenzas, including the H5N1 subtype, are a primary concern for 
potential global health threats.  H5N1 influenza is a main concern due to its severe disease 
progression and high case fatality rate, which is greater than 50%. Although, some of the 
pathology of infection is understood, finer mechanisms of disease progression remain unclear.  
Due to its increasing incidence rate after its reemergence in 2003, H5N1 has become a primary 
target for public health and vaccine research to prepare for a potential species cross-overs with 
pandemic potential.  
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3.0 Specific Aims 
 
Mechanisms that govern immune recognition and response, as well as cellular 
mechanisms during disease pathogenesis, in H5N1 highly pathogenic avian influenza remain 
unclear. To elucidate effects of H5N1 infection of the lung in cynomologus macaques this 
project focuses on the ability of H5N1 influenza to generate fulminant pneumonia and to induce 
cell death of alveolar epithelial cells. I aim to characterize cellular mechanisms occurring within 
the lung, to both better understand immunologic responses to H5N1 infection and to identify 
possible targets for therapeutics. My overarching hypothesis is that after H5N1 aerosol 
inoculation lung epithelial cells undergo caspase-1 dependent pyroptosis, leading to recruitment 
signaling of neutrophils to the site of infection and the production of NETs as secondary host 
immune response. 
 
 
Aim 1: Characterize and Identify Caspase-1 Inflammatory Cascade within Lung of 
Cynomologus Macaques Infected with H5N1 Influenza Virus 
 
 This aim seeks to characterize caspase-1 inflammatory cascade within the lung of our 
infected H5N1 model. To start, I aim to characterized of hallmarks of caspase-1 inflammatory 
cascade and caspase-1 mediated pyroptosis including: caspase-1, IL-1β, and ASC expression 
within H5N1 infected lung tissue samples via immunofluorescent staining. In addition, I aim to 
quantitatively analyze areas associated with staining patterns from hallmarks of caspase-1 
mediated pro-inflammatory in naïve and infected animal groups. Secondly, I aim to identify 
22 
 
cellular origin of IL-1β signaling via immunofluorescence, to characterize which cell types at the 
sites of infection express initial IL-1β after viral infection during H5N1 HPAI disease.  
 
Aim 2: Characterize and Identify Origins of Neutrophil Signaling and NETosis within 
H5N1 Infected Cynomologus Macaque Lungs 
 
 This aim seeks to characterize origins of neutrophil recruitment signaling and NETs from 
NETosis of neutrophils within lung tissue samples. To do so I first aim to identify of Il-18 
signaling from alveolar epithelial cells via immunoflourescent staining in situ. A second aim is to 
identify NETosis in lung tissue after aerosol challenge of H5N1 influenza via staining lung tissue 
with immunoflourescent stains of H3 histones from citrullinated histones. This is to associate 
NET production via innate immune responses from neutrophils to H5N1 infection. 
 
Aim 3: Correlate Caspase-1 and NETosis to Disease Severity 
 
 This aim seeks to correlate caspase-1 and NETs from NETosis to H5N1 influenza 
disease severity.  To do so I aim to correlate previous study data on fludeoxyglucose imagining 
via positron emission tomography (FDG PET-CT) scans of infected animals with Caspase-1 and 
NETs expression in infected tissue [11].  In addition, I aim to correlate Caspase-1 and NETs 
with brochiole lavage albumin levels collected from previous study data [11]. Finally, I aim to 
correlate caspase-1 expression with NET expression to identify if caspase-1 mediated disease 
is related to NET expression from recruited neutrophils. 
  
23 
 
 
4.0 Methods and Materials  
 
4.1 Tissues Used in This Study 
 
Tissue samples obtained for use in this study were collected from a previous study 
completed by Wonderlich et. al,  in which seven adult female cynomologus macaques were 
exposed to live viral strain A/Vietnam/1203/2004 aerosol within a BSL3+ laboratory.  The 
aerosol used in the previous study were approximately 4 µm in diameter and viral titers 
averaged at 6.72 log10 PFU (Table 2) [11].  Cynomologus macaques from the previous study 
were exposed for 15-30 minutes duration via a head only exposure unit connected to a Aeroneb 
Solo nebulizer (Aerogen, Deerfield, IL) [11].   Naïve controls were obtained via an additional 3 
healthy female cynomologus macaques.  All animals either passed due to rapid respiratory 
disease, with 3 animals dying, or were euthanized, between 2 and 6 days post infection. The 
mean time of death due to disease progression or humane sacrifice was 3.2 days (Table 2). The 
tissues used in the current work were fixed in 2% paraformaldehyde for 4 hours and infused 
with 30% sucrose overnight prior to cryopreservation.  
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Table 2. Characteristics of Animal Aerosol Exposure and Naïve Controls 
 Animal ID Aerosol Viral 
Titer (log10 PFU) 
Time to 
death 
(days) 
 
 
 
 
H5N1 
Infected 
M132 7.26 3 
M133 7.17 2* 
M134 7.07 6* 
M135 6.16 3 
M136 6.46 2* 
M137 6.37 2* 
M138 6.57 4 
 Mean of 
Infected 
Exposure 
6.72 3.2 
 
Naïve 
Controls 
M59+ ------- N/A 
M139+ ------- N/A 
M163+ ------- N/A 
 
*-animal humanely Sacrificed + - Naïve Control Animal without aerosol exposure 
Table of aerosol exposure and time to death. 
 
4.2 Slide Preparation 
 
Tissue slides were cut on a Cryostat microtome.  The blade of the microtome was 
changed to ensure clean cuts prior to use.  Section were cut at 6 µm, and laid against plus 
superfrost microscope slides with environmental heat and freezing attaching the tissue ribbons 
to slides. Slides were incubated overnight at -20°C prior to staining to allow rest time for newly 
prepared tissue sections.  
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4.3 In Situ Immunofluorescence 
 
Immunohistochemistry was performed on sections fixed with 2% paraformaldehyde from 
cryopreserved tissue collected during the previous study. Sections were blocked in 5% serum 
prior to addition of the primary antibody for 1 hour and 30 minutes or overnight exposure 
depending on the primary antibody used. Between staining periods, a wash of 0.5% serum was 
added and removed from each section, with at least one wash incubating for at least 3 minutes.  
Each secondary antibody used was incubated at 4°C for one hour prior to removal.  The 
following antibodies were used: mouse anti-pan cytokeratin (AE1/AE3; Abcam), mouse anti-
human calprotectin Ab-1 (MAC397; ThermoScientific), anti-influenza A nucleoprotein (DPJY03; 
BEI resources), anti-IL-1β/IL-1F2 (6E10; Novus Biologics), anti-ASC (B-3, Santa Cruz 
Biotechnology), anti-caspase-1 p20 (C-15, Santa Cruz Biotechnology), anti-caspase-1 (D-3, 
Santa Cruz Biotechnology), anti-influenza A nucleoprotein polyclonal Ab (PA5-32242, 
ThermoScientific), anti-IL-18 (10663-1-AP, Proteintech), and anti-histone H3 (P68431, Abcam). 
Secondary antibodies were from Thermo Fischer Scientific and included goat anti-mouse IgG2α 
Alexa Fluor 488, goat anti-mouse IgG2α Alexa Fluor 647, goat anti-mouse IgG1 Alexa Fluor 
546, donkey anti-goat IgG Alexa Fluor 488, donkey anti-rabbit IgG Alexa Fluor 488, and donkey 
anti-rabbit IgG Alexa Fluor 546. Cell nuclei were identified using membrane-permeable Hoescht 
dye and slides were mounted in ProLong Diamond Antifade mountant (P36965, Thermo Fischer 
Scientific).  All staining included appropriately concentrated isotype-matched control antibody. 
Slides were images on Olympus Fluoview FV1000 confocal microscope from the University of 
Pittsburgh Center for Biologic Imaging.  Images were captured at 1024 x 1024 pixels ratio at 10 
pixels per microsecond at various objective focal points including: 20x, 40x, 60x, or 100x 
objective focus.  
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4.4 Image Analysis and Quantification of Staining 
 
Quantitative analysis of dual staining patterns were used to compare statistical 
differences between naïve and post-infected animal groups.   Tissue sections collected were not 
normalized for size and viral titer, as sections were collected during necropsy from the previous 
aerosol challenge study [11]. To normalize for size differentiation and exposure differentiation, 
each section was non-repetitively imaged a total of ten times per slide per stain and these 
quantitative results were averaged for each individual animal. These images were analyzed with 
Nis Elements ver. 5.11.00, and areas of active staining were quantitatively examined and 
recorded for each of the ten fields across the tissue. Areas of active staining were examined 
with binary area quantification, where each pixel of an image is given a value between 0 and 1, 
and the total area is then related to the total number of available pixel in the image.  Binary 
areas of stain were averaged across the ten focal points for each tissue, and a median of 
staining intensity from all post-infected slides and all naïve slides was established as used for 
comparisons. 
 
4.5 Statistical Analysis 
 
All statistical analysis was performed in Prism v6.0 (GraphPad Software).  A p value 
<0.05 was considered significant. All analysis was performed using two tailed, nonparametric 
tests between infected and control animals. Data collected was averaged for either post-infected 
or naïve control groups. The averages of log10 were calculated as geometric means. 
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5.0 Results 
 
5.1 Aim 1 
 
Although the actions of  caspase-1 and IL-1β as well as other pro-inflammatory cytokines 
and chemokines have been previously elucidated during seasonal influenza, as well as through 
aerosolized challenge of H5N1 influenza, effects of these cytokines and their cells of origin 
points still require further clarification. In this vein, the first aim of this project was to identify 
hallmarks of the caspase-1 pro-inflammatory cascade within infected snap frozen lung tissue 
collected during necropsy following aerosolized challenge of H5N1 virus [11].  
 
5.1.1 Hallmarks of the Caspase-1 Pro-Inflammatory Cytokine Cascade 
 
5.1.1.1 Caspase-1 in Association with Influenza A Nucleoprotein 
 
Necropsied snap frozen tissues of lung were collected at varying time points following 
aerosolized challenge. Tissues were sectioned and sections were stained with antibodies to 
caspase-1 and influenza A nucleoprotein.  Sections were prepared at 6 µm and stained with a 
monoclonal caspase-1 immunofluorescence antibody and a polyclonal influenza A 
nucleoprotein antibody. Sections were examined under 40x objective focus on an Olympus 
Fluoview 1000 confocal microscope to identify caspase-1 and influenza A nucleoprotein co-
localization. The influenza A nucleoprotein marker was chosen for its cross-reactivity with 
seasonal influenza A strains and our H5N1 HPAI strain, A/Vietnam/1203/2004. Co-localization 
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of caspase-1 and H5N1 virus was our initial step to identify pro-inflammatory cytokine 
generation after viral challenge. 
 
 
Figure 1. Caspase-1 and Influenza A Nucleoprotein Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen lung tissues stained for polyclonal active caspase-1 and 
monoclonal influenza A nucleoprotein. Caspase-1 was stained with Alexa fluor 546, and appears red in 
coloration. Influenza A nucleoprotein was stained with Alexa fluor 488, and appears green in coloration. 
Hoechst dye was used to identify nuclei in cells. Scale bars, 100 µm.  
 
 Following staining, each post-infection time point showed a large amount of caspase-1 
and influenza A nucleoprotein, as well as high cellular condensation due to swelling from local 
pulmonary inflammation after aerosol challenge.  Each infected macaque tissue also had high 
visible background of DAPI Hoeshct stain (data not shown). Hoeshct staining normally is used 
to identify nuclei of cells within deep lung, but this staining pattern with high visible background 
was attributable to large amounts of albumin and sputum generated via secondary infection and 
the resultant fulminant pneumonia. Naïve tissues collected from control animals during the 
aerosolized H5N1 mock challenge had minimal to no amount of caspase-1 expression (Figure 
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1).  Staining co-localization suggests expression of caspase-1 mediated pro-inflammatory 
cytokine cascade as a result of viral infection of epithelial cells.  Although minimally expressed 
within naïve tissue, I wished to quantitatively identify the increase in pro-inflammatory caspase-1 
and compare quantitative areas of stain from both naive and infected animals. 
 
 
Figure 2. Quantification of Caspase-1  
Quantification of caspase-1 within necropsied snap frozen tissues from post-infected and naïve animals 
stained with caspase-1.  Data points refer to multiple dual stained sections per animal, where dual stained 
sections where stained either with influenza A nucleoprotein or IL-1β along with caspase-1. The p values 
were determined through Mann-Whitney U tests. *p < 0.05, **p<0.01. 
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Figure 3. Quantification of Influenza A Nucleoprotein  
Quantification of influenza A nucleoprotein within necropsied snap frozen tissues from post-infected and 
naïve animals dual stained with influenza A nucleoprotein and caspase-1.  The p values were determined 
through Mann-Whitney U tests. *p < 0.05. 
 
 
 When comparing the infected and naïve animal groups a statistical increase in caspase-
1 expression was present in infected tissue sections (Figure 2).  Influenza A nucleoprotein was 
also determined to have a statistical increase when compared against our naïve slides (Figure 
3). Furthermore, we analyzed the staining of caspase-1 alone versus caspase-1 that co-
localized with influenza a nucleoprotein in deep lung tissue sections, and found that caspase-1 
within infected animal tissues, was statistically found to be co-localized with influenza A 
nucleoprotein rather than un-associated with influenza A nucleoprotein (Figure 4).   Co-
localization of caspase-1 and influenza A nucleoprotein suggests caspase-1 mediated pro-
inflammatory cytokine cascade expression after viral challenge (Figure 4). 
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Figure 4. Quantification of Co-localization of Caspase-1 and Influenza A Nucleoprotein  
Quantification of co-localization of caspase-1 with influenza A nucleoprotein. The p values were determined 
through Mann-Whitney U tests. *p < 0.05 
 
5.1.1.2 Caspase-1 in associated with IL-1β 
 
 After identification of caspase-1 and influenza A nucleoprotein within our infected and 
naïve tissue, we wanted to correlate the staining of caspase-1 and IL-1β to identify both the 
primary and secondary hallmarks of the caspase-1 pro-inflammatory cytokine cascade leading 
to potential pyroptotic cell death of tissue within our deep lung sections. To do so necropsied 
tissues collected from the previous study were sectioned and stained with monoclonal 
antibodies specific for active caspase-1 and IL-1β. Co-localization of the stains was observed 
and quantitatively analyzed (Figures 5 and 6).  
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Figure 5. Caspase-1 and IL-1β Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal active caspase-1 and 
monoclonal active IL-1β. Caspase-1 was stained with Alexa fluor 546, and appears red in coloration. IL-1β 
was stained with Alexa fluor 647, and appears green in coloration. Hoechst dye was used to identify nuclei 
in cells. Scale bars, 100 µm.  
 
Similar to our caspase-1 staining in tissues, IL-1β staining showed a statistical increase 
between naïve and post-infected tissues (Figure 6).  Furthermore, we analyzed the staining of 
IL-1β alone versus IL-1β that co-localized with caspase-1 in our deep lung tissue. We found that 
IL-1β within the tissues that were imaged was statistically non-co-localized with caspase-1 
(Figure 7). This data further supports caspase-1 mediated pro-inflammatory cytokine cascades 
after vial challenge. This data suggests that there is not a one to one correlation between active 
caspase-1 and active IL-1β. Pro-IL-1β is normally cleaved by active caspase-1, suggesting each 
active caspase-1 substrate may cleave more than one pro-IL-1β.  
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Figure 6. Quantification of IL-1β  
Quantification of IL-1β within necropsied snap frozen tissues from post-infected and naïve animals stained 
with IL-1β. Data points refer to multiple dual stained sections per animal, where dual stained sections where 
stained either with caspase-1, anti-H3 histones, or anti-ASC along with IL-1β. The p values were determined 
through Mann-Whitney U tests. *p < 0.05, **p<0.01,***p < 0.0001. 
 
 
Figure 7. Quantification of Co-localization of Caspase-1 and IL-1β 
Quantification of co-localization of caspase-1 with IL-1β. The p values were determined through Mann-
Whitney U tests. *p < 0.05, **p<0.01.  
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5.1.2 Caspase-1 Mediated Pyroptotic Cell Death  
 
 
5.1.2.1 ASC protein associated with IL-1β 
 
  After identifying both caspase-1 associated with our H5N1 influenza nucleoprotein and 
caspase-1 associated with IL-1β, we wanted to identify hallmarks of caspase-1 mediated 
pyroptotic cell death within our deep lung tissues. To do so I looked at a marker of 
inflammasome generation and a marker of pyroptotic cell death via cellular membrane rupture, 
apoptosis speck like protein containing a card domain, otherwise known as ASC. Sections from 
necropsied tissue were stained with monoclonal antibodies for ASC and active IL-1β to identify 
potential co-localization (Figure 8). Images collected from these sections were quantitatively 
analyzed via NIS elements as stated in the materials and methods section of this thesis to 
identify statistical differences between ASC protein in both naïve and post-infected tissues 
(Figure 9).  
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Figure 8. Anti-ASC and IL-1β Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal ASC and monoclonal 
active IL-1β. Anti-ASC was stained with Alexa fluor 546, and appears red in coloration. IL-1β was stained 
with Alexa fluor 647, and appears green in coloration. Hoechst dye was used to identify nuclei in cells.  
Scale bars, 100 µm. Arrows indicate punctate morphology from ASC oligomerization.  
 
 
Figure 9. Quantification of Anti-ASC  
Quantification of anti-ASC within necropsied snap frozen tissues from post-infected and naïve animals dual 
stained with anti-ASC and IL-1β. The p values were determined through Mann-Whitney U tests. *p < 0.05. 
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Figure 10. Quantification of Co-localization of Anti-ASC and IL-1β 
Quantification of co-localization of anti-ASC with IL-1β. The p values were determined through Mann-
Whitney U tests. *p < 0.05, **p<0.01.  
 
 ASC had no significant increase between infected and naïve animal groups (Figure 9).  
In immunoflourescent staining, ASC was seen as speck like puncta through some of the tissue, 
which may be due to the formation of ASC oligomers instead of ASC interacting with another 
inflammasome complex (Figure 8).  When quantitatively analyzed, there was a significant 
difference between IL-1β which co-located and IL-1β that did not co-located with ASC, which 
may be due to multiple cleavages of IL-1β from individual cells (Figure 10). ASC, either in its 
oligomer form or in conjunction with other inflammasome complexes, is active in lung tissue with 
pro-inflammatory IL-1β, which suggests pyroptotic death of cells in infected tissue, such as 
alveolar epithelial cells.  
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5.1.3 Cellular Origin of IL-1β Signaling  
 
 
To identify co-localized IL-1β staining with its cellular origin, and identify which cells 
could be potential origins of IL-1β signaling after viral challenge sections were stained for IL-1β 
and a cellular marker, such as cytokeratin to mark alveolar epithelial cells, calprotectin to mark 
neutrophils, and CD163 to mark macrophages within the lung.  
 
5.1.3.1 IL-1β signaling from Alveolar Epithelial Cells 
 
 
In dual stains with cytokeratin as a  marker for alveolar epithelial cells we saw clear co-
localization visible in an orange color due to the overlap of our Alexa Fluor 488 green stain and 
our red Alexa Fluor 546 staining (Figure 11). Importantly, a large amount of co-localization 
seems to occur in alveolar epithelial cells, which outline alveolar spaces, and in some of the 
terminal bronchioles that could account for large amount of recruited cells seen in BAL fluids 
obtained from the previous study. This data suggests that IL-1β cytokine signaling is generated 
from alveolar epithelial cells, and that these alveolar epithelial cells are generating pro-
inflammatory cytokines after viral challenge.  
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Figure 11. Cytokeratin and IL-1β Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal cytokeratin, to mark 
alveolar epithelial cells, and monoclonal active IL-1β. Cytokeratin was stained with Alexa fluor 546, and 
appears red in coloration. IL-1β was stained with Alexa fluor 647, and appears green in coloration. Hoechst 
dye was used to identify nuclei in cells. Scale bars, 100 µm. 
  
5.1.3.2 IL-1β signaling from Neutrophils 
 
 
Similar to our cytokeratin staining, we saw clear co-localization between calprotectin, a 
marker for neutrophils recruited to the site of infection, and IL-1β (Figure 12). Neutrophils at the 
site of infection appear to generate pro-inflammatory cytokines, such as IL-1β, in areas of 
infected tissue.  
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Figure 12. Calprotectin and IL-1β Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal calprotectin, to mark 
alveolar recruited or alveolar neutrophils, and monoclonal active IL-1β. Calprotectin was stained 
secondarily with Alexa fluor 546, and appears red in coloration. IL-1β was stained secondarily with Alexa 
fluor 647, and appears green in coloration. Hoechst dye was used to identify nuclei in cells.  Scale bars, 
100 µm. 
 
 
5.1.3.3 IL-1β signaling from Macrophages 
 
 
 CD163, a macrophage marker for alveolar macrophages and macrophages recruited to 
the site of infection, was stained in tissue alongside IL-1β.  Unlike our previous cell markers, 
there is no apparent co-localization of CD163 and IL-1β, however there is a large recruitment of 
macrophages to the site of infection compared to our naïve tissue sections (Figure 13). Pro-
inflammatory cytokine generation does not appear to orginate from macrophages at the site of 
infection, even with large populations of macrophage within infected deep lung tissue.  
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Figure 13. CD163 and IL-1β Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal CD163, to mark 
alveolar macrophages, and monoclonal active IL-1β. CD163 was stained secondarily with Alexa fluor 546, 
and appears red in coloration. IL-1β was stained secondarily with Alexa fluor 647, and appears green in 
coloration. Hoechst dye was used to identify nuclei in cells. Scale bars, 100 µm. 
 
5.1.4 Aim 1 Conclusions 
 
 
At the conclusion of aim 1, I found that high expression of caspase-1 co-localized with 
influenza A nucleoprotein suggest a correlation between caspase-1 mediated pro-inflammatory 
cytokine generation and H5N1 influenza disease.  This conclusion was further support by high 
expressions of IL-1β and ASC in situ, which suggest caspase-1 mediated pro-inflammatory 
cytokine generation and caspase-1 mediated pyroptosis in infected tissues. Finally, I found that 
co-localizations of IL-1β and cytokeratin or calprotectin, our markers for epithelial cells and 
neutrophils, suggest that both alveolar epithelial cells and neutrophils express IL-1β in response 
to infection in lung tissue.  
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5.2  Aim 2 
 
 
 During the previous study large amounts of pro-inflammatory cytokines and chemokines 
were collected through bronchoalveolar lavage (BAL) fluid and tissue necropsy after aerosolized 
challenge of H5N1 highly pathogenic avian influenza [11]. Some effects of these cytokines and 
their origination points are known, however others require further clarification. The second aim 
of this project was twofold, first to identify IL-18 generation from alveolar epithelial cells, and 
secondly to identify NETosis from recruited or alveolar neutrophils at the sites of infection.  
 
5.2.1 IL-18 Staining Within Alveolar Epithelial Cell Sections 
 
 
 IL-18 is hypothesized to act as the recruitment cytokine signaling for recruited 
neutrophils within the deep tissue of the lung. Alveolar epithelial cells were hypothesized as the 
origin for IL-18 expression. Identification of IL-18 in tissue sections, prepared at 6 µm thickness, 
was completed via staining for antibodies to IL-18 and cytokeratin, a marker for alveolar 
epithelial cells.   
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Figure 14. Cytokeratin and IL-18 Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal CD163, to mark 
alveolar macrophages, and monoclonal IL-18. Cytokeratin was stained secondarily with Alexa fluor 546, 
and appears red in coloration. IL-18 was stained secondarily with Alexa fluor 488, and appears green in 
coloration.  Hoechst dye was used to identify nuclei in cells. Scale bars, 100 µm. 
 
 In dual stains with cytokeratin and IL-18 some co-localization was observed (Figure 14). 
Staining within epithelial cell cytosol suggested cytokine production, as seen with the green 
staining. This data suggests that alveolar epithelial cells are the source of IL-18 cytokine 
signaling in lungs during influenza, and recruit neutrophils to the site of infection.  
 
5.2.2 NETosis of Neutrophils Within Deep Lung Tissue  
 
 
   To identify NETosis within virus-challenged tissues, dual immunoflourescent stains for 
antibodies to both H3 histones and either influenza A nucleoprotein or active IL-1β were used. 
An H3 histone antibody marker was used to identify citrullinated histones, as nucleoprotein from 
NETs is citrullinated when produced through vital or suicidal NETosis. Infected tissues with both 
influenza A nucleoprotein dual stains and IL-1β dual staining showed high expressions of H3 
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histone NETs within deep lung tissue, compared to naive tissue sections (Figures 15 and 16). 
More specifically, influenza A nucleoprotein corrleated with potentially infected neutrophils and 
seen in areas of high H3 expression (Figure 15).  As well, areas of H3 staining had high 
expression of IL-1β cytokine when compared to naïve tissues (Figure 15). Co-localization of 
influenza A nucleoprotein and H3 histones suggests infected neutrophils in the deep lung and 
NETosis during viral challenge. Pro-inflammatory IL-1β co-localized with H3 histones 
exemplifies the pro-inflammatory nature of NETosis.  These sites of infection with pro-
inflammatory signaling and H3 citrullinated histones from alveolar or recruited neutrophils, 
suggest the presence of NETosis during disease progression.  
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Figure 15. Influenza A Nuceloprotein and Anti-H3 Histone Immunoflourescent Staining in 
situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal influenza A 
nucleoprotein and monoclonal anti-H3 Histone. Influenza A nucleoprotein was stained secondarily with 
Alexa fluor 546, and appears red in coloration. Anti-h3 histone was stained secondarily with Alexa fluor 
488, and appear green in coloration. Hoechst dye was used to identify nuclei in cells.  Scale bars, 100 µm. 
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Figure 16. IL-1β and Anti-H3 Histone Immunoflourescent Staining in situ 
Infected and naïve necropsied snap frozen deep lung tissues stained for monoclonal influenza A 
nucleoprotein and monoclonal anti-H3 Histone. IL-1β was stained secondarily with Alexa fluor 647, and 
appears red in coloration. Anti-h3 histone was stained secondarily with Alexa fluor 488, and appear green 
in coloration. Hoechst dye was used to identify nuclei in cells. Scale bars, 100 µm. 
 
After observing high expression of H3 Histone NETs in infected tissues, images were 
recaptured and utilized in quantitaitve analysis via Nis Elements. Compared to naïve tissues, 
citrullinated h3 histones were significantly increased in post-infected tissue sections (Figure 17). 
When analyzing co-localization of IL-1β with H3 histones in post-infected tissue slides, no 
difference between H3 co-localized with IL-1β and IL-1β by itself was found(Figure 18). These 
data suggest that compared to naïve tissue, NETosis is highly expressed in infected tissue.  It 
appears that although previous studies have shown the pro-inflammatory nature of NETs, there 
is not a significant increase in IL-1β expression from infected area with high NET expression.  
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Figure 17. Quantification of Anti-H3 Histone  
A) Quantification of anti-H3 Histone within necropsied snap frozen tissues from post-infected and naïve 
animals dual stained with anti-H3 Histone and IL-1β. The p values were determined through Mann-Whitney 
U tests. *p < 0.05. 
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Figure 18. Quantification of Co-localization of Anti-H3 Histone and IL-1β 
Quantification of co-localization of anti-H3 histone with IL-1β. The p values were determined through Mann-
Whitney U tests. *p < 0.05.  
 
 
5.2.3 Aim 2 Conclusions 
 
In aim 2, I found that IL-18 co-localized with cytokeratin, our marker for epithelial cells, 
suggesting that alveolar epithelial cells generate neutrophil cytokine signaling in infected 
tissues.  A high expression of H3 histones in infected tissues suggest that NETosis of 
neutrophils is occurring in lungs infected with H5N1.  Finally, NETosis and IL-1β co-localization 
suggest pro-inflammatory cytokine expression in area that express NETs or affirms the IL-1β 
generation from NETs located in the ECM.  
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5.3 Aim 3 
 
While the data in the previous aims does point to active capase-1 and NETs within the 
lower respiratory tract of animals, the data does not relate directly to disease severity after 
aerosol challenge. To determine if animals exposed to H5N1 influenza aerosol had disease 
severity related to caspase-1 and NETs expression we examined previous recorded data from 
the study completed by Wonderlich et. al [11].  As part of this previous study, all animals who 
were challenged via H5N1 influenza aerosol also underwent molecular imaging via 
fludeoxyglucose positron emission tomography-computer tomography (FDG PET-CT) [11].  
FDG is a radiotracer used to measure cellular activity, and when used with PET-CT you are 
able to visualize cell activity associated with tomography of the site of infection, for instance 
measuring cellular inflammation from H5N1 influenza infection in the lower respiratory track.  In 
addition, animals in the infected group also had concentrations of albumin measured from BAL 
fluids.  Albumin levels in the previous study were analyzed to determine if alveolar epithelial cell 
death was a contributing factor to fluid leakage after ARDs development from disease 
progression [11].  
 To identify if caspase-1 and NETs are associated with disease progression or severity, 
quantitative analysis of the data collected from the previous study and the data collected during 
this study was completed.  
 
5.3.1 Caspase-1 and NETs in Clinical Disease 
 
When correlating caspase-1 with FDG PET-CT, we found a positive correlation with a p 
value of 0.0167 (Figure 19).  Similarly, we found a positive correlation with NETs expression 
and high inflammation levels measured through FDG PET-CT (Figure 19). As stated above, 
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FDG PET-CT is a measure of cellular activity related to tomography at the site of infection. In 
the previous study, FDG PET-CT was used to cell inflammatory responses after aerosol 
challenge [11].  Both of the positive correlations above, point to caspase-1 and NETs being 
directly associated with inflammation from H5N1 HPAI aerosol challenge and disease severity.   
When comparing albumin levels collected from BAL completed in our infected animal 
group, neither caspase-1 or NETs correlated positively with an increase in albumin levels 
(Figure 20). As stated previously, alveolar epithelial cell death was suggested to contribute to 
fluid leakage in the alveolar space and lead to ARDs in cynomologus macaques. As shown in 
the previous study, increased albumin levels were found in BAL fluid from cynomologus 
macaques infected with H5N1 [11]. However correlate data presented in this study, suggests 
that caspase-1 and NETs do not have a direct association with fluid presentation from H5N1 
influenza disease progression, and may not be contributing to fluid accumulation after alveolar 
cell death.  
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Figure 19. Caspase-1 and NETs in Clinical disease
Caspase-1 binary areas from immunoflourescent staining in situ plotted against FDG PET-CT standardized 
uptake values.  Fludeoxyglucose (FDG) PET-CT is used to identify areas of high cellular activity, marking 
inflammation at sites of infection. Caspase-1 is used as a marker for caspase-1 mediated pro-inflammatory 
cytokine pathways.  B) NETs binary areas from immunoflourescent staining in situ against FDG PET-CT 
standardized uptake values. FDG PET-CT is used to identify areas of high cellular activity, marking 
inflammation at sites of infection. NETs are used to identify neutrophil extracellular traps generated through 
NETosis. Each point presented is an individual animal that was challenged with H5N1 influenza aerosol.The 
p values were determined through Spearman r correlates. *p < 0.05. 
Figure 20. Caspase-1 and NETs Compared Against Albumin Levels 
A) Caspase-1 binary areas from immunoflourescent staining in situ against albumin levels measured
through BAL. B) NETs binary areas from immunoflourescent staining in situ against albumin levels. Each
point presented is an individual animal that was challenged with H5N1 influenza aerosol. The p values
were determined through Spearman r correlates. *p < 0.05.
51 
After correlating caspase-1 and NETs with FDG PET-CT, I decided to correlate caspase-
1 and NETs to see if caspase-1 expression was associated with NET expression from recruited 
neutrophils. A positive correlation between caspase-1 and NETs was found suggesting that 
area that express caspase-1 also are likely to express NETosis and that the two are associated 
with disease severity after H5N1 influenza aersol challenge (Figure 21).  
Figure 21. Caspase-1 Correlated with NETs in situ 
Caspase-1 binary areas from immunoflourescent staining in situ correlated to NETs binary area from 
immonuflourescent staining in situ. Each point presented is an individual animal, including naive controls 
and the infected group. The p values were determined through Spearman r correlates. *p < 0.05. 
5.3.2 Aim 3 Conclusions 
At the end of aim 3, I found that caspase-1 and NET expression in infected tissues are 
correlated to disease severity in cynomologus macaques infected by H5N1 aerosol. I found that 
caspase-1 and NETs do not have direct relationships to increases in albumin found in BAL 
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fluids.  Finally, I found that caspase-1 and NETs expressed in infected tissues are correlated. 
This correlation suggest that caspase-1 pro-inflammatory cytokine generation leads to cytokine 
recruitment of neutrophils who undergo NETosis in H5N1 infected tissues. 
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6.0 Discussion 
 
  
 In previous studies, severe disease progression during H5N1 highly pathogenic avian 
influenza has been shown to increase pro-inflammatory cytokines within the lower respiratory 
tract and systemically through the body in both humans and non-human primates [11, 21, 101].  
Further clarifcation of disease mechanisms at a cellular level is required to better understand 
viral infection.  Previous groups have elucidated the effect of viral challenge at a cellular level 
within the lung and have found apoptotoic cell death of pneumocytes and alveolar epithelial 
cells within both human and non-human primate samples [102, 103].  While apoptotic cell death 
may occur in infected lung tissues, this fails to explain the high expression of cytokines within 
the lung.  Apoptotic cell death also fails to explain the large amount of fluid present, leading to 
secondary fulminant pneumonia in both cynamolgus macques and human infected with H5N1.  
Furthermore, previous studies involving H5N1 influenza do not fully recapitulate natural course 
of disease as most introduce viral challenge via intra-tracheal liquid suspension alongside 
inoculum to the eyes, nose, or mouth.  Tissue samples collected from a previous study, 
Wonderlich et. al, and used in this study were instead challenged via aeroslized H5N1 and show 
disease progression more akin to natural course of disease in human cases[11]. Aerosol 
infection has also demonstrated high pro-inflammatory cytokines expression, similar to natural 
disease progression, and mean death times are comparable to those seen in natural infection.  
 With study data from the previous study more akin to natural infection, I expected to see 
pro-inflammatory cytokine expression to be much higher in infected tissues rather than naïve 
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tissues.  Not only did I find high expression of pro-inflammatory cytokines, but as well I found 
them to be correlated to influenza A nucleoprotein and to inflammasome related protein ASC.  
Quantitative and qualitative analysis of in situ immunoflourescent staining show high titers of 
caspase-1, IL-1β, and IL-18 as expected. These pro-inflammatory cytokines are all associated 
with caspase-1 mediated pro-inflammatory cytokine pathway.  High concentrations of ASC 
protein within the tissues along with caspase-1 mediated cytokine expression suggest pyroptotic 
cellular disease progression within deep lung, most likely occuring within infected alveolar 
epithelial cells.  Data from this study strengthens findings of pyroptotic cellular death driven by 
caspase-1, either simultaneously occuring with or insead of apoptotic cellular death.  Ultimately 
these data point to caspase-1 mediated disease progression, and pro-inflammatory pyroptotic 
cell death of alevolar epithelial cells after viral challenge.  
 As suggested in Webster et. al, inhibition of cytokine production within H5N1 infected 
mice did not prevent or protect mice from death during lethal influenza challenge [111].  The 
study tested TNF-α, IL-6, CCL2, and glucocorticoids within mice and looked for differentiation 
between genetically deficient mice for these cytokines and steroids.  While TNF-α, IL-6, CCL2, 
and glucocorticoids are important in disease progression, within their study they do not seem to 
have a generative effect for disease.  In Wonderlich et. al, pro-inflammatory cytokine expression 
was dramatically increased in non-human primates challenged with aersolized H5N1, especially 
titers of IL-1β found in both tissues and bronchoalveolar lavages (BALs) [11].  With the data 
presented via this study, I expected to see high titers of IL-1β expressed in situ of H5N1 post-
infected cyanomolgus macques.  As the data demonstrate, not only do infected animals exhibit 
high titers of IL-1β, but they also exhibit its effector cytokine, caspase-1, and Il-18.  This data 
suggests that pro-inflammatory cytokines are abundant in disease, and may be an essential part 
of disease progression. Furthermore, the data suggests that caspase-1 mediated disease 
progression may be a driving force for severe influenza after viral challenge.  
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 High expression of IL-18 as seen in a previous study done by Wonderlich et. al, has 
been hypothesized to be a recruitment signal for neutrophils to the site of infection [11]. I 
expected that in situ staining of infected tissues would affirm high concentrations of Il-18.  As the 
data suggest IL-18 in addition to other cytokines from the caspase-1 mediated pro-inflammaotry 
cytokine pathway are highly expressed in post infected tissues.  This data suggests that IL-18 
signaling from alveolar epithelial cells recruits neutrophils to the site of infection after aerosol 
challenge. Furthermore, large populations of neutrophils and macrophages were found in 
infected tissue, affirming the results of high populations found in BALs and tissues from 
Wonderlich et. al [11].  
 As suggested in Wonderlich et. al, after H5N1 influenza infection there is a large 
recruitment of neutrophils to the site of infection [11].  Narasaraju et. al found not only large 
recruitment of neutrophils in severe season influenza A infection, but NETosis within alevolar 
spaces attributing to complications during secondary pneumococcal infection [112].  As a result, 
I expected to see an increase in neutrophil numbers and NETS within infected tissue as 
compared to naïve tissue sections.  As the data suggest, not only is there a large number of 
neutrophils at the site of infection, but there is also large amount of expressed citrullinated H3 
histone in relation to vital or suicidal NETosis. The staining and quantitative data show a 
statistically significant increase in citrullinated h3 histone associated with NETs.  NETs within 
H5N1 infected samples demostrate NETosis during primary viral disease progression and or 
during sceondary infection of pneumoncoccal bacteria leading to fulminant pneumonia. 
Furthermore, in situ immunoflourecence demonstrates alveolar tissue inflammation and leaking 
of interstitial fluid in to alveolar spaces. The data suggests presentation of NETs within the deep 
lung that trap both viral particulate and bacteria, as well as fluids from leakage of interstitum 
after tearing of alveolar tissue. This “double edged sword” action may exacerbate disease, 
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cause hyperventilation, and decrease tidal volumes as seen in Wonderlich et. al after 
aerosolized viral challenge. 
 As a final part to this study I wished to correlated disease severity with presentation of 
caspase-1 and NETs within lower respiratory tract tissue. As the data suggests the animals 
infected via aerosol exposure, in the study completed by Wonderlich et. al, have high correlates 
of disease severity with both caspase-1 and NETosis [11]. This affirms the notion that caspase-
1 mediated disease cooperates with severe disease progression alognside NETosis of 
neutrophils recruited to the site of infection. In addition, the data suggests that areas of infection 
with high NETosis also present high levels of pro-inflammatory caspase-1. All together the data 
suggests that caspase-1 and NETosis develop as a result of severe disease progression and 
may be targets for furture therapeutic treatments.  
 A prime limitation of this study is the power associated with the statistical analysis 
performed on the quatitative imaging.  The number of tissue samples available for study were 
limited and the variation in disease progression across animals did not distribute evenly.  As a 
result instead of individual day time point analysis, groups of infected and naïve tissue were 
used. In addition the number of images taken for each tissue was lower than expected due to 
the limited number of tissues available for sectioning.  Further experimentation on live animal 
models and ex vivo samples, as well as more image analysis would be beneficial to confirm 
statistically significant increases in cytokine expression and NETS expression when comparing 
post-infected and naïve groups.  
 Overall this data suggest the expression of caspase-1 mediated pro-inflammatory 
cytokine pathways after H5N1 viral infection, in additon to the development of NETs from 
alveolar and recruited neutrophils after H5N1 viral infection. Identification of caspase-1 
mediated disease progression and NETs within deep lung tissue of non-human primates 
infected with H5N1 highly pathogenic avian influenza allows for clarification of cellular disease 
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mechanism.  Additionally, identification of these cellular disease mechanisms can act as 
potential targets for therapeutics.  
Currently HPAI A infection preparedness revolves around active vaccination of both farm 
workers who handle domestic avian populations, and active vaccination of vectors who have the 
potential to be infected including domestic and wild fowl [113]. Although benefical, this leaves a 
large gap in preparedness especially regarding an animal cross-over event of a highly 
pathogenic influenza A virus.  A cross over event of a novel highly pathogenic avian influenza 
strain could lead to pandemic scale infection and is highly detrimental to public health efforts. 
Therapeutic and cure research in H5N1 and other types of highly pathogenic influenza A viruses 
is therefore a necessity.  Introduction of novel therapeutics could assist in limiting the number of 
fatal cases of H5N1 highly pathogenic avian influenza and reduce the case fatality ratio found 
from previous infection of both cynomologus macaques and human cases. While this data is 
only a start towards novel therapeutics, cure and therapeutic research must proceed alongside 
cellular disease mechanisms in order to prevent H5N1 highly pathogenic avian influenza cross 
over events and to further benefit public health research.  
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7.0 Future Work 
 
 
 While the data presented suggest caspase-1 mediated pro-inflammatory cytokine 
pathways within deep lung after viral challenge further research into cellular mechanisms is still 
required.  In order to determine pyroptotic cell death within tissue, experiments identifying active 
gasdermin d, the pore forming complex in pyroptotic cell death, must be completed.  Further 
work into the therapeutic benefits of caspase-1 inhibition could lead to novel therapeutics.  In 
addition, research into the effects of DNAse on clearance of NETs within the deep lung in a live 
model could prove to be beneficial as a therapeutic treatment. Finally identification of active 
inflammasome complexes within the deep lung that interact with ASC, or further identification of 
ASC pyroptosomes within deep lung tissue could prove to be useful in finding potential site for 
cure or therapeutic research. Full elucidation of cellular mechanisms of disease can prove 
beneficial to both therapuetic and cure research, as well as assist in understanding other types 
of severe pulmonary viral infections.  
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